Drug
WS016 clinical trials
Also written WS016.
Keep track of what changes. Save the WS016 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- WS016
- 2
Studies by the year they started
4 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Waterstone Pharmaceutical (Wuhan) Co., LTD. (4)
Studies
Open first, then newest update. How each study uses WS016 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaRecruitingPhase 3Waterstone Pharmaceutical (Wuhan) Co., LTD.NCT07881965Written as WS016
- A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of HyperkalemiaRecruitingPhase 3Waterstone Pharmaceutical (Wuhan) Co., LTD.NCT07251309Written as WS016
- A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia.RecruitingPhase 2Waterstone Pharmaceutical (Wuhan) Co., LTD.NCT06277128Written as WS016 3g
- The Safety and Tolerability of WS016 in Healthy Chinese VolunteersCompletedPhase 1Waterstone Pharmaceutical (Wuhan) Co., LTD.NCT06281470Written as WS016 Single Dose(6g)